Endo-ERN webinar: Update on congenital hyperinsulinism


On Tuesday July 6th at 16:00 – 17:00 CET an Endo-ERN webinar about “Update on congenital hyperinsulinism” will be given by Oliver Blankenstein, Peter Kühnen, Sebastian Kummer, Alena Welters and Thomas Meissner from Charité – Universitätsmedizin Berlin / Universitätsklinikum Düsseldorf.

Congenital hyperinsulinism is the most frequent cause of severe transient and persistent neonatal hypoglycemia. The etiology and the clinical course are highly variable. Today, we still find a high proportion of patients suffering from hypoglycemic brain damage.

This update will focus on the rational approach to evaluation and management of a patient with suspected hyperinsulinism. Efforts to improve the neurological outcome need to focus on the initial management in the first days of life, even before the diagnosis of hyperinsulinism. The further management includes evaluation of clinical presentation as well as laboratory parameters, genetics, PET-scan and histology in those patients that need surgery. Finally, we will discuss new aspects of medical and surgical treatment.

Webinar summary

WebinarUpdate on congenital hyperinsulinism
DateJuly 6th, 2021
Time16:00 – 17:00 hr
SpeakersOliver Blankenstein
Peter Kühnen
Sebastian Kummer
Thomas Meissner
Alena Welters
RegistrationRegistration is closed